文献速递类风湿关节炎

类风湿关节炎风险人群症状问卷(SPARRA)的初步验证与结果:一项EULAR项目

Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project.
PubMed 文献 · RMD Open · 2018-05-21

该EULAR项目开发了用于类风湿关节炎(RA)风险人群的SPARRA症状问卷,并在219例风险个体(74%类风湿因子和/或抗瓜氨酸化蛋白抗体阳性,26%血清阴性)中评估其心理测量学特性并量化症状。问卷内容效度和表面效度高,重测信度好,但结构效度低至中等、反应性低(小亚组)。风险个体症状负担高,疼痛、僵硬和疲劳最常见且对日常功能影响大;18例RA患者一级亲属症状负担较低但分布相似。

要点

  • SPARRA问卷在RA风险人群中表面效度和内容效度高,1周和6个月重测信度好。
  • 结构效度低至中等,同时效度较高,提示部分问题反映常规VAS未捕捉的症状内容。
  • 血清阴性和阳性风险个体症状负担均高,疼痛、僵硬和疲劳最常见且对日常功能影响大。

核心结论

  • SPARRA问卷具有良好的心理测量学特性,可为RA风险个体的现有临床测量补充信息。
  • 研究人群症状负担和影响高。
  • 未来研究应评估SPARRA数据能否改善RA风险个体的预测。

研究设计与样本

  • 问卷条目源自血清阳性关节痛患者的定性研究。
  • 问卷施用于219例基于症状或自身抗体阳性确定的RA风险个体:74%类风湿因子和/或抗瓜氨酸化蛋白抗体阳性,26%血清阴性。
  • 评估了效度、信度和反应性,并以18例RA患者一级亲属作为对照。

主要发现

  • 表面效度和内容效度高。
  • 重测(1周和6个月)显示良好的一致性和信度。
  • 总体结构效度低至中等,同时效度较高,提示部分问题反映常规视觉模拟量表疼痛/健康状况未捕捉的症状内容。
  • 反应性低(小亚组)。
  • 血清阴性和血清阳性风险个体症状负担均高,疼痛、僵硬和疲劳最常见且对日常功能影响大。

关键数值与推荐

  • 219例RA风险个体中74%类风湿因子和/或抗瓜氨酸化蛋白抗体阳性,26%血清阴性。
  • 18例RA患者一级亲属用于比较。
  • 重测信度评估时间为1周和6个月。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 结构效度低至中等。
  • 反应性低(小亚组)。
  • 未来研究应评估SPARRA数据能否改善RA风险个体的预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To describe the development and assess the psychometric properties of the novel 'Symptoms in Persons At Risk of Rheumatoid Arthritis' (SPARRA) questionnaire in individuals at risk of rheumatoid arthritis (RA) and to quantify their symptoms. METHODS: The questionnaire items were derived from a qualitative study in patients with seropositive arthralgia. The questionnaire was administered to 219 individuals at risk of RA on the basis of symptoms or autoantibody positivity: 74% rheumatoid factor and/or anticitrullinated protein antibodies positive, 26% seronegative. Validity, reliability and responsiveness were assessed. Eighteen first degree relatives (FDR) of patients with RA were used for comparison. RESULTS: Face and content validity were high. The test-retest showed good agreement and reliability (1 week and 6 months). Overall, construct validity was low to moderate, with higher values for concurrent validity, suggesting that some questions reflect symptom content not captured with regular Visual Analogue Scale pain/well-being. Responsiveness was low (small subgroup). Finally, the burden of symptoms in both seronegative and seropositive at risk individuals was high, with pain, stiffness and fatigue being the most common ones with a major impact on daily functioning. The FDR cohort (mostly healthy individuals) showed a lower burden of symptoms; however, the distribution of symptoms was similar. CONCLUSIONS: The SPARRA questionnaire has good psychometric properties and can add information to currently available clinical measures in individuals at risk of RA. The studied group had a high burden and impact of symptoms. Future studies should evaluate whether SPARRA data can improve the prediction of RA in at risk individuals.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. van Beers-Tas MH, Ter Wee MM, van Tuyl LH, et al. Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project. RMD Open. 2018. PMID: 29862044. doi:10.1136/rmdopen-2017-000641

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。